iPhone Competition
advanced search

Welcome: Guest

log in

0 items in basket Total: £0
$0 / €0

View Basket

Emerging Pharmaceutical Markets Globally

Publication Date April 2008
Publisher RNCOS
Product Type Report
Pages 125
ISBN Number not applicable
Product Code RCS00409
Price

£765.00
approximately: $1,500 | €971

PDF Buy Now
PRINT £915 ($1,800 | €1,165) Buy Now
CD-ROM £915 ($1,800 | €1,165) Buy Now
Order above formats by FAX Order by FAX

Summary

The report "Emerging Pharmaceutical Markets Globally" provides an exhaustive overview of the pharmaceutical markets in the E7 countries (Brazil, Russia, India, China, Mexico, Turkey and Indonesia). This Report provides a detailed account of the factors that are redefining the structure and composition of the global pharmaceutical market and causing a shift in growth from the mature markets to the emerging ones.

Statistics and analysis regarding market size, growth, structure, exports and imports, therapy mix, share of branded and generic drugs, healthcare financing, market share of key players, as well as key drivers and restraints and trends in technology development have been thoroughly analyzed in this report.

The report also envisages the fact that the markets in the E7 have huge differences as compared to the developed markets in terms of traditional therapies, intellectual property, health insurance scenario and so forth. Thus, it provides valuable information to pharmaceutical companies and investors looking to foray into these markets and help them devise strategies according to the E7 markets.

Key Findings

  • The E7 Pharmaceutical markets are expected to grow at a CAGR 11.5% between 2007 and 2012 reaching revenues worth nearly US$ 116 Billion. In contrast the G7 Pharmaceutical markets are projected to grow at CAGR 4.95% between the same periods.
  • The pharmaceutical markets in India, China and Turkey are expected to grow the fastest among all the E7 nations.
  • The E7 nations are expected to account for nearly half of the 6.99 Billion global populations in 2012.
  • Cardiovascular, cancer and other chronic diseases have taken over communicable diseases as the biggest killers in these nations.
  • The Pharmaceutical market in most of these regions is still dominated by acute therapies, but with the growth rate of chronic therapies far exceeding that of acute therapies, the therapy mix of the market will be much different in the next five years from what it is today.
  • The markets in India, China, Russia and Indonesia are dominated by generics. Generics however have a lower penetration in Brazil, Mexico and Turkey.
  • Inadequate protection of intellectual property and large-scale prevalence of counterfeit drugs remains a major challenge faced by the pharmaceutical industry in these regions.

Key Issues & Facts Analyzed

  • Evaluation of past, current and future market trends.
  • Evaluation of the market by segment.
  • Discussion about the major drivers of the pharmaceutical market.
  • Analysis of the opportunities created by the market.
  • Analysis of the major challenges faced by the market.
  • Competitive landscape of the market.

Key Players Analyzed

This section provides the overview, key facts and financial information of prominent players in the E7 pharmaceutical market like GlaxoSmithKline, Sanofi-Aventis, Pfizer Inc., Novartis, and AstraZeneca.

Research Methodology Used

Information Sources

Information has been sourced from books, newspapers, trade journals, and white papers, industry portals, government agencies, trade associations, monitoring industry news and developments, and through access to more than 3000 paid databases.

Analysis Methods

The analysis methods include ratio analysis, historical trend analysis, and linear regression analysis using software tools, judgmental forecasting, and cause and effect analysis.

Content

  • 1. Analyst View
  • 2. Global Pharmaceutical Market
    • 2.1 Market Size
    • 2.2 Mature Markets - G7 Countries
    • 2.3 Emerging Markets - E7 Countries
    • 2.4 E7 Countries to Grow Strongly
  • 3. Why E7 Pharmaceutical Market?
    • 3.1 Economic Growth
    • 3.2 Income Level
    • 3.3 Population Base
    • 3.4 Prevalence of Lifestyle-related Diseases
    • 3.5 Medical & Distribution Infrastructure
    • 3.6 Health Insurance
  • 4. Industry Performance
    • 4.1 Brazil (Past, Present & Future Scenario)
      • 4.1.1 Macroeconomic Indicators
      • 4.1.2 Population Profile
      • 4.1.3 Disease Profile
      • 4.1.4 Healthcare Spending & Financing
      • 4.1.5 Pharmaceutical Market
      • 4.1.6 Import & Export
      • 4.1.7 Generic Drugs
      • 4.1.8 Therapy Areas
      • 4.1.9 Key Players
    • 4.2 Russia (Past, Present & Future Scenario)
      • 4.2.1 Macroeconomic Indicators
      • 4.2.2 Population Profile
      • 4.2.3 Disease Profile
      • 4.2.4 Healthcare Spending & Financing
      • 4.2.5 Pharmaceutical Market
      • 4.2.6 Import
      • 4.2.7 Branded & Generic Drugs
      • 4.2.8 Therapy Areas
      • 4.2.9 Key Players
    • 4.3 India (Past, Present & Future Scenario)
      • 4.3.1 Macroeconomic Indicators
      • 4.3.2 Population Profile
      • 4.3.3 Disease Profile
      • 4.3.4 Healthcare Spending & Financing
      • 4.3.5 Pharmaceutical Market
      • 4.3.6 Import & Export
      • 4.3.7 Branded & Generic Drugs
      • 4.3.8 Therapy Areas
      • 4.3.9 Key Players
    • 4.4 China (Past, Present & Future Scenario)
      • 4.4.1 Macroeconomic Indicators
      • 4.4.2 Population Profile
      • 4.4.3 Disease Profile
      • 4.4.4 Healthcare Spending & Financing
      • 4.4.5 Pharmaceutical Market
      • 4.4.6 Import & Export
      • 4.4.7 Branded & Generic Drugs
      • 4.4.8 Therapy Areas
      • 4.4.9 Key Players
    • 4.5 Turkey (Past, Present & Future Scenario)
      • 4.5.1 Macroeconomic Indicators
      • 4.5.2 Population Profile
      • 4.5.3 Disease Profile
      • 4.5.4 Healthcare Spending & Financing
      • 4.5.5 Pharmaceutical Market
      • 4.5.6 Import & Export
      • 4.5.7 Branded & Generic Drugs
      • 4.5.8 Therapy Areas
      • 4.5.9 Key Players
    • 4.6 Mexico (Past, Present & Future Scenario)
      • 4.6.1 Macroeconomic Indicators
      • 4.6.2 Population Profile
      • 4.6.3 Disease Profile
      • 4.6.4 Healthcare Spending & Financing
      • 4.6.5 Pharmaceutical Market
      • 4.6.6 Import & Export
      • 4.6.7 Branded & Generic Drugs
      • 4.6.8 Therapy Areas
      • 4.6.9 Key Players
    • 4.7 Indonesia (Past, Present & Future Scenario)
      • 4.7.1 Macroeconomic Indicators
      • 4.7.2 Population Profile
      • 4.7.3 Disease Profile
      • 4.7.4 Healthcare Spending & Financing
      • 4.7.5 Pharmaceutical Market
      • 4.7.6 Import & Export
      • 4.7.7 Branded & Generic Drugs
      • 4.7.8 Key Players
  • 5. Opportunities
    • 5.1 Chronic Diseases
    • 5.2 Pharma Outsourcing Market
    • 5.3 Vaccine Market
    • 5.4 Medical Devices Market
  • 6. Restraining Forces
    • 6.1 Counterfeit Drugs
    • 6.2 Patent Protection
    • 6.3 Traditional Medicines
  • 7. Key Players
    • 7.1 GlaxoSmithKline
    • 7.2 Sanofi-Aventis
    • 7.3 Pfizer Inc.
    • 7.4 Novartis
    • 7.5 AstraZeneca
  • List of Figures:
    • Figure 2-1: Global - Pharmaceutical Market* (in Billion US$), 2001-2007E
    • Figure 2-2: Global - Forecast for Pharmaceutical Market* (in Billion US$), 2008-2012
    • Figure 2-3: G7 Countries - Pharmaceutical Markets (in Billion US$), 2007E
    • Figure 2-4: G7 Countries - Forecast for Pharmaceutical Markets (in Billion US$), 2012
    • Figure 2-5: G7 Countries - CAGR Growth of Pharmaceutical Markets (%), 2007-2012
    • Figure 2-6: E7 Countries - Pharmaceutical Markets (in Billion US$), 2007E
    • Figure 2-7: E7 Countries - Forecast for Pharmaceutical Markets (in Billion US$), 2012
    • Figure 2-8: E7 Countries - CAGR Growth of Pharmaceutical Markets (%), 2007-2012
    • Figure 2-9: Global - Pharmaceutical Market by E7 & G7 Countries (%), 2007E & 2012F
    • Figure 2-10: Global - Share of E7 & G7 Countries in Pharmaceutical Market Growth (%), 2007-2012
    • Figure 3-1: G7 Countries - Real GDP (in Trillion US$), 2004 & 2012F
    • Figure 3-2: E7 Countries - Real GDP (in Trillion US$), 2004 & 2012F
    • Figure 3-3: Global - Share of E7 & G7 Countries in Population (%), 2007E & 2012F
    • Figure 3-4: Relative Per Capita Spending on Drugs by Age Group
    • Figure 3-5: India - Prevalence of various Lifestyle-related Diseases (in Million), 2005 & 2015F
    • Figure 4-1: Brazil - Nominal GDP (in Billion US$), 2005-2012F
    • Figure 4-2: Brazil - Consumer Price Index (%), 2005-2012F
    • Figure 4-3: Brazil - Currency Exchange Rate (From US$ to BRL), 2005-2012F
    • Figure 4-4: Brazil - Foreign Direct Investment (in Billion US$), 2004-2007
    • Figure 4-5: Brazil - Population (in Million), 2005-2012F
    • Figure 4-6: Brazil - Breakup of Population by Age Group (%), 2005-2012F
    • Figure 4-7: Brazil - Population in the Age Group of 65 Years & Above (in Million), 2005-2012F
    • Figure 4-8: Brazil - Number of Deaths due to Leading Causes (in '000), 2005
    • Figure 4-9: Brazil - Breakup of Deaths by various Causes (%), 2005-2012F
    • Figure 4-10: Brazil - Per Head Healthcare Spending (in US$), 2004-2012F
    • Figure 4-11: Brazil - Breakup of Healthcare Payment by Source (%), 2006
    • Figure 4-12: Brazil - Pharmaceutical Market (in Billion BRL), 2001, 2002 & 2004-2007E
    • Figure 4-13: Brazil - Pharmaceutical Market (in Billion Units), 2004-2007E
    • Figure 4-14: Brazil - Forecast for Pharmaceutical Market (in Billion BRL), 2008-2012
    • Figure 4-15: Brazil - Pharmaceutical Imports (in Billion US$), 2004-2007E
    • Figure 4-16: Brazil - Pharmaceutical Exports (in Million US$), 2004-2007E
    • Figure 4-17: Brazil - Generic Drugs (in Million US$), 2004-2007E
    • Figure 4-18: Brazil - Forecast for Generic Drugs (in Million US$), 2008-2012
    • Figure 4-19: Brazil - Share of Generic Drugs in Pharmaceutical Market* (%), 2007E & 2012F
    • Figure 4-20: Brazil - Breakup of Pharmaceutical Market by Segment (%), Dec 2007
    • Figure 4-21: Russia - Nominal GDP (in Billion US$), 2005-2012F
    • Figure 4-22: Russia - Consumer Price Index (%), 2005-2012F
    • Figure 4-23: Russia - Currency Exchange Rate (From US$ to RUB), 2005-2012F
    • Figure 4-24: Russia - Foreign Direct Investment (in Billion US$), 2004-2007
    • Figure 4-25: Russia - Population (in Million), 2005-2012F
    • Figure 4-26: Russia - Breakup of Population by Age Group (%), 2005-2012F
    • Figure 4-27: Russia - Population in the Age Group of 65 Years & Above (in Million), 2005-2012F
    • Figure 4-28: Russia - Number of Deaths due to Leading Causes (in '000), 2005
    • Figure 4-29: Russia - Breakup of Deaths by various Causes (%), 2005-2012F
    • Figure 4-30: Russia - Per Head Healthcare Spending (in US$), 2004-2012F
    • Figure 4-31: Russia - Breakup of Healthcare Payment by Source (%), 2005
    • Figure 4-32: Russia - Domestic Pharmaceutical Market (in Billion US$), 2005-2007E
    • Figure 4-33: Russia - Domestic Pharmaceutical Market by Segment (in Billion US$), 2005-2007E
    • Figure 4-34: Russia - Forecast for Domestic Pharmaceutical Market (in Billion US$), 2008-2012
    • Figure 4-35: Russia - Pharmaceutical Imports (in Billion US$), 2005-2007E
    • Figure 4-36: Russia - Breakup of Pharmaceutical Market* by Branded & Generic Drugs (%), 2005
    • Figure 4-37: India - Nominal GDP (in Billion US$), 2005-2012F
    • Figure 4-38: India - Consumer Price Index (%), 2005-2012F
    • Figure 4-39: India - Currency Exchange Rate (From US$ to INR), 2005-2012F
    • Figure 4-40: India - Foreign Direct Investment (in Billion US$), 2002-03 to 2006-07
    • Figure 4-41: India - Foreign Direct Investment in Pharmaceutical Market (in Million US$), 2003-04 to 2006-07
    • Figure 4-42: India - Population (in Million), 2005-2012F
    • Figure 4-43: India - Breakup of Population by Age Group (%), 2005-2012F
    • Figure 4-44: India - Population in the Age Group of 65 Years & Above (in Million), 2005-2012F
    • Figure 4-45: India - Number of Deaths due to Leading Causes (in '000), 2005
    • Figure 4-46: India - Breakup of Deaths by various Causes (%), 2005-2012F
    • Figure 4-47: India - Per Head Healthcare Spending (in US$), 2005-2012F
    • Figure 4-48: India - Breakup of Healthcare Payment by Source (%), 2006
    • Figure 4-49: India - Domestic Pharmaceutical Market* (in Billion INR), 2001-02 to 2006-07
    • Figure 4-50: India - Forecast for Domestic Pharmaceutical Market* (in Billion INR), 2007-08 to 2011-12
    • Figure 4-51: India - Pharmaceutical Imports (in Billion INR), 2000-01 to 2006-07E
    • Figure 4-52: India - Pharmaceutical Exports (in Billion INR), 2005-06 to 2011-12F
    • Figure 4-53: India - Breakup of Domestic Pharmaceutical Market by Segment (%), 2004 & 2010F
    • Figure 4-54: India - Share of Top Players in Pharmaceutical Market (%), 2006
    • Figure 4-55: China - Nominal GDP (in Billion US$), 2005-2012F
    • Figure 4-56: China - Consumer Price Index (%), 2005-2012F
    • Figure 4-57: China - Currency Exchange Rate (From US$ to CNY), 2005-2012F
    • Figure 4-58: China - Foreign Direct Investment (in Billion US$), 2004-2007
    • Figure 4-59: China - Population (in Million), 2005-2012F
    • Figure 4-60: China - Breakup of Population by Age Group (%), 2005-2012F
    • Figure 4-61: China - Population in the Age Group of 65 Years & Above (in Million), 2005-2012F
    • Figure 4-62: China - Number of Deaths due to Leading Causes (in '000), 2005
    • Figure 4-63: China - Breakup of Deaths by various Causes (%), 2005-2012F
    • Figure 4-64: China - Per Head Healthcare Spending (in US$), 2004-2012F
    • Figure 4-65: China - Breakup of Healthcare Payment by Source (%), 2006
    • Figure 4-66: China - Domestic Pharmaceutical Market (in Billion US$), 1996, 2000 & 2005-2007E
    • Figure 4-67: China - TCM Market (in Billion CNY), 2005-2007E
    • Figure 4-68: China - Pharmaceutical Purchase by Source (%), 2003
    • Figure 4-69: China - Forecast for Domestic Pharmaceutical Market (in Billion US$), 2008-2012
    • Figure 4-70: China - Medicine & Health Product Imports (in Billion US$), 2005-2007E
    • Figure 4-71: China - Breakup of Medicine & Health Product Imports by Type (%), 2006
    • Figure 4-72: China - Medicine & Health Product Exports (in Billion US$), 2005-2007E
    • Figure 4-73: China - Breakup of Medicine & Health Product Exports by Type (%), 2006
    • Figure 4-74: China - Breakup of Domestic Pharmaceutical Market by Segment (%), 2003
    • Figure 4-75: Turkey - Nominal GDP (in Billion US$), 2005-2012F
    • Figure 4-76: Turkey - Consumer Price Index (%), 2005-2012F
    • Figure 4-77: Turkey - Currency Exchange Rate (From US$ to TRY), 2005-2012F
    • Figure 4-78: Turkey - Foreign Direct Investment (in Billion US$), 2004-2007
    • Figure 4-79: Turkey - Population (in Million), 2005*-2012F
    • Figure 4-80: Turkey - Breakup of Population by Age Group (%), 2005*-2012F
    • Figure 4-81: Turkey - Population in the Age Group of 65 Years & Above (in Million), 2005*-2012F
    • Figure 4-82: Turkey - Number of Deaths due to Leading Causes (in '000), 2005
    • Figure 4-83: Turkey - Breakup of Deaths by various Causes (%), 2005-2012F
    • Figure 4-84: Turkey - Per Head Healthcare Spending (in US$), 2004-2012F
    • Figure 4-85: Turkey - Breakup of Healthcare Payment by Source (%), 2005
    • Figure 4-86: Turkey - Domestic Pharmaceutical Market (in Billion US$), 2005-2007E
    • Figure 4-87: Turkey - Domestic Pharmaceutical Market (in Million Boxes), 2002-2007E
    • Figure 4-88: Turkey - Forecast for Domestic Pharmaceutical Market (in Billion US$), 2008-2012
    • Figure 4-89: Turkey - Breakup of Pharmaceutical Market* by Imported & Locally-produced Drugs (%), 2004-2007E
    • Figure 4-90: Turkey - Pharmaceutical Exports (in Million US$), 2004-2007E
    • Figure 4-91: Turkey - Breakup of Pharmaceutical Market Sales Value* by Branded & Generic Drugs (%), 2004- 2007E
    • Figure 4-92: Turkey - Breakup of Pharmaceutical Market Sales Volume* by Branded & Generic Drugs (%), 2004-2007E
    • Figure 4-93: Mexico - Nominal GDP (in Billion US$), 2005-2012F
    • Figure 4-94: Mexico - Consumer Price Index (%), 2005-2012F
    • Figure 4-95: Mexico - Currency Exchange Rates (From US$ to MXN), 2005-2012F
    • Figure 4-96: Mexico - Foreign Direct Investment (in Billion US$), 2004-2007
    • Figure 4-97: Mexico - Population (in Million), 2005-2012F
    • Figure 4-98: Mexico - Breakup of Population by Age Group (%), 2005-2012F
    • Figure 4-99: Mexico - Population in the Age Group of 65 Years & Above (in Million), 2005-2012F
    • Figure 4-100: Mexico - Number of Deaths due to Leading Causes (in '000), 2005
    • Figure 4-101: Mexico - Breakup of Deaths by various Causes (%), 2005-2012F
    • Figure 4-102: Mexico - Per Head Healthcare Spending (in US$), 2004-2012F
    • Figure 4-103: Mexico - Breakup of Healthcare Payment by Source (%), 2004
    • Figure 4-104: Mexico - Domestic Pharmaceutical Market (in Billion Pesos), 2004-2007E
    • Figure 4-105: Mexico - Forecast for Domestic Pharmaceutical Market (in Billion Pesos), 2008-2012
    • Figure 4-106: Mexico - Pharmaceutical Imports (in Billion US$), 2003 & 2007E
    • Figure 4-107: Mexico - Pharmaceutical Exports (in Billion US$), 2003, 2006 & 2007E
    • Figure 4-108: Mexico - Breakup of Pharmaceutical Market* by Branded & Generic Drugs (&), 2004
    • Figure 4-109: Mexico - Generic Market (in Billion MXN), 2003 & 2004
    • Figure 4-110: Mexico - Share of Top Players in Pharmaceutical Market (%), 2007
    • Figure 4-111: Indonesia - Nominal GDP (in Billion US$), 2005-2012F
    • Figure 4-112: Indonesia - Consumer Price Index (%), 2005-2012F
    • Figure 4-113: Indonesia - Currency Exchange Rates (From US$ to Rp), 2005-2012F
    • Figure 4-114: Indonesia - Foreign Direct Investment (in Billion US$), 2005-2007
    • Figure 4-115: Indonesia - Population (in Million), 2005-2012F
    • Figure 4-116: Indonesia - Breakup of Population by Age Group (%), 2005-2012F
    • Figure 4-117: Indonesia - Population in the Age Group of 65 Years & Above (in Million), 2005-2012F
    • Figure 4-118: Indonesia - Number of Deaths due to Leading Causes (in '000), 2005
    • Figure 4-119: Indonesia - Breakup of Deaths by various Causes (%), 2005-2012F
    • Figure 4-120: Indonesia - Per Head Healthcare Spending (in US$), 2004-2012F
    • Figure 4-121: Indonesia - Breakup of Healthcare Payment by Source (%), 2003
    • Figure 4-122: Indonesia - Domestic Pharmaceutical Market (in Billion Rp), 2000-2007E
    • Figure 4-123: Indonesia - Prescription & OTC Drugs Market (in Billion Rp), 2000-2007E
    • Figure 4-124: Indonesia - Forecast for Domestic Pharmaceutical Market (in Billion Rp), 2008-2012
    • Figure 4-125: Indonesia - Pharmaceutical Exports (in Billion Rp) 2001-2005
    • Figure 4-126: Indonesia - Pharmaceutical Imports (in Billion Rp) 2001-2005
    • Figure 4-127: Indonesia - Breakup of Pharmaceutical Market by Branded & Generic Drugs (%), 2005
    • Figure 4-128: Indonesia - Share of Top Players in Prescription Pharmaceutical Market (%), 2005
    • Figure 4-129: Indonesia - Share of Top Players in OTC Pharmaceutical Market (%), 2005
    • Figure 5-1: Global - Pharma Outsourcing Market by Segment (%), 2006
    • Figure 5-2: BRIC Countries - Medical Device Market (in Million US$), 2006
  • List of Tables:
    • Table 2-1: Global - Pharmaceutical Market* by Region (in Billion US$), 2006
    • Table 3-1: E7 Countries - Disposable Income (in Million US$), 2007E & 2012F
    • Table 3-2: G7 Countries - Population (in Million), 2007E & 2012F
    • Table 3-3: E7 Countries - Population (in Million), 2007E & 2012F
    • Table 3-4: G7 Countries - Population in the Age Group of 65 Years & Above (in Million), 2007E & 2012F
    • Table 3-5: E7 Countries - Population in the Age Group of 65 Years & Above (in Million), 2007E & 2012F
    • Table 4-1: Brazil - Statistics of Top 10 Players in Pharmaceutical Market, 2006
    • Table 4-2: Russia - Statistics of ATC Groups in Commercial Drugs Market, 2006
    • Table 4-3: Russia - Statistics of ATC Groups under DLO Programme, 2006
    • Table 4-4: Russia - Performance of Key Players in Pharmaceutical Market* (in Million US$), 2005 & 2006
    • Table 4-5: Russia - Performance of Key Players in Pharmaceutical Market (%), H1 2006 & H1 2007
    • Table 4-6: India - Performance of Drugs by Therapeutic Segment in Domestic Pharmaceutical Market (%), 2006
    • Table 4-7: India - Performance of Top 20 Pharmaceutical Players, 2006
    • Table 4-8: China - Performance* of Drugs by Therapeutic Segment in Pharmaceutical Market (%), 2005 & 2006
    • Table 4-9: China - Performance* of Key Players in Pharmaceutical Market (H1 2006 & H1 2007)
    • Table 4-10: Turkey - Performance* of Therapy Areas in Pharmaceutical Market (%), 2005 & 2006
    • Table 4-11: Turkey - Top 20 Pharmaceutical Players by Sales Value (Jan-Sep 2007)
    • Table 4-12: Turkey - Top 20 Pharmaceutical Players by Sales Volume (Jan-Sep 2007)
    • Table 4-13: Mexico - Performance of Therapy Areas in Retail Pharmaceutical Market, 2006
    • Table 5-1: India - Market for Various Chronic Diseases (in Billion INR), 2006 & 2010F
    • Table 5-2: India, China & Brazil - Vaccine Market (in Million US$), 2006E & 2010F
    • Table 7-1: GlaxoSmithKline - Key Financials (in Million US$), 2004-2006
    • Table 7-2: Sanofi-Aventis - Key Financials (in Million US$), 2004-2006
    • Table 7-3: Pfizer Inc. - Key Financials (in Million US$), 2004-2006
    • Table 7-4: Novartis - Key Financials (in Million US$), 2004-2006
    • Table 7-5: AstraZeneca - Key Financials (in Million US$), 2004 & 2005

back to top

About this Product
Delivery Details

PDF:Delivered by email within 12 to 24 hours of placing the order (Mon-Fri)
PRINT/CD-ROM:Despatched within 2 to 4 working days.

Ask a question about this product?

Need help finding the right product?

Related Products
Recently Viewed Products
Emerging Pharmaceutical Markets Globally

Industry Events

Realising the Commercial Potential of Therepeutic Antibodies

30 Sep 08 to 01 Oct 08
London, UK
view summary >>

6th Annual: Clinical Trial Supplies and Packaging Summit

24 Sep 08 to 25 Sep 08
Amsterdam, Netherlands
view summary >>

BioProduction 2008

28 Oct 08 to 29 Oct 08
Dusselfdorf, Germany
view summary >>

Intelligent comment on RBlog
#

Pharma & Healthcare

Customer Services

How to Buy
Formats & Delivery
Terms & Conditions
Account Options
Login/Register

call +44 (0) 20 7060 7474
or email us

Resources

Why Report Buyer?
Advertising/Affiliates
View Our Publishers
News
About Us
Meet Us
Jobs
Contact Us
Categories and Subcategories

Post it

Del.icio.us
StumbleUpon
Reddit

logo: AddThis